Skip To Main Content
Jinani Jayasekera on Muck Rack

Jinani Jayasekera

As seen in: JAMA (The Journal of the American Medical Association), JAMA Network, JAMA: Journal of the American Medical Association, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jinani

Contact Jinani, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tailored Exercise Strategies and Mortality Among Breast Cancer Survivors

|
By Jinani Jayasekera
| JAMA Network Verified
Supplement 1. eMethods 1. Supplemental methods eTable 1. Summary of the CHALLENGE randomized trial, specification of the target trial that approximately mirrored it, and two target trial emulations eTable 2. List of exercise activities included in the Arizona Activity Frequency Questionnaire eTable 3. Summary of covariates and models used in the two target trial emulations eTable 4. Summary of sensitivity analyses implemented in the second target trial emulation eTable 5.
Open in Who Shared Issue with article?

Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions | Journal of Clinical Oncology

|
By Jinani Jayasekera, Joseph A. Sparano, Suzanne O'Neill, Claudine Isaacs
| ascopubs.org
More than 180,000 women in the United States are annually diagnosed with hormone-receptor–positive (HR+), human epidermal growth factor receptor-2–negative (HER2–), axillary lymph node–negative breast cancer.1 Up to 85% of these women could remain distant recurrence-free at 10 years with adjuvant endocrine therapy alone, and the remainder may benefit from chemoendocrine therapy.
Open in Who Shared Issue with article?

Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and Outcomes

|
By Jinani Jayasekera, Susan T Vadaparampil, Susan Eggly, Tanina Foster Moore
| ascopubs.org
The 21-gene recurrence score (RS) assay is used to guide breast cancer treatment decisions but can be poorly understood by patients. We examined the effects of a question prompt list (QPL) on knowledge, distress, and decisional conflict related to genomic testing and treatment in early-stage breast cancer. We describe the feasibility and acceptability of the QPL and the impact of the QPL on knowledge, distress, and decisional conflict before and after the receipt of the QPL (MEND 2, N = 65).
Open in Who Shared Issue with article?
See all 8 licensed articles (9 Total)